Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female Subjects

NCT04097288 is registered in ClinicalTrials.gov with University Hospital Bispebjerg and Frederiksberg as lead sponsor.

NCT NCT04097288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04097288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female Subjects
Lead sponsor
University Hospital Bispebjerg and Frederiksberg
Phase
Phase 1
Overall status
Completed
Start date
September 17, 2019
Completion date
May 1, 2020
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fecal incontinence, stress urinary incontinence